Arkolith/Insider Trading/FUSN/Form 4

Bobilev Dmitri

Chief Medical OfficerFusion Pharmaceuticals Inc. (FUSN) · full profile →Form 4 · filed Jan 5, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
0 non-derivative · 2 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 4, 2024Grant(A)152K—$0152K
Jan 4, 2024Grant(A)91K—$091K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-24-002293) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML